Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Laryngeal Diseases × linrodostat × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Lymphoid Interstitial Pneumonia 1 Laryngeal Diseases 1 Glioblastoma 1 Endometrial Adenocarcinoma 1 Carcinoma, Squamous Cell 1

Interventions

monalizumab 1 linrodostat 1 durvalumab 1 Surgical Flaps 1 Nivolumab 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03854032 2025-06-06

Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck

Thomas Jefferson University

Phase 2 Active not recruiting

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡